blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0546099

EP0546099 - Use of human Interferon gamma 4-134 [Right-click to bookmark this link]
Former [1993/24]HUMAN INTERFERON-$g(g)4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS
[1994/41]
StatusNo opposition filed within time limit
Status updated on  12.08.1995
Database last updated on 31.08.2024
Most recent event   Tooltip03.05.2002Lapse of the patent in a contracting state
New state(s): ES
published on 19.06.2002  [2002/25]
Applicant(s)For all designated states
Schering Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033 / US
[N/P]
Former [1993/24]For all designated states
SCHERING CORPORATION
2000 Galloping Hill Road
Kenilworth New Jersey 07033 / US
Inventor(s)01 / NARULA, Satwant, K.
26 Natalie Drive
West Caldwell, NJ 07006 / US
02 / LUNDELL, Daniel, J.
21 Sleepy Hollow Drive
Flemington, NJ 08822 / US
[1993/24]
Representative(s)Ritter, Stephen David, et al
Mathys & Squire LLP 120 Holborn London
EC1N 2SQ / GB
[N/P]
Former [1993/24]Ritter, Stephen David, et al
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL / GB
Application number, filing date91917729.529.08.1991
[1993/24]
WO1991US05982
Priority number, dateUS1990057624531.08.1990         Original published format: US 576245
[1993/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9204377
Date:19.03.1992
Language:EN
[1992/07]
Type: A1 Application with search report 
No.:EP0546099
Date:16.06.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 19.03.1992 takes the place of the publication of the European patent application.
[1993/24]
Type: B1 Patent specification 
No.:EP0546099
Date:12.10.1994
Language:EN
[1994/41]
Search report(s)International search report - published on:EP19.03.1992
ClassificationIPC:A61K37/66, C07K13/00
[1994/41]
CPC:
C07K14/57 (EP); A61P35/00 (EP); A61K38/00 (EP)
Former IPC [1993/24]C07K13/00, A61K37/66
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/24]
TitleGerman:Verwendungsmethoden von humanem Gammainterferon 4-134[1994/41]
English:Use of human Interferon gamma 4-134[1994/41]
French:L'utilisation d'Interferon gamma 4-134 d'origine humaine[1994/41]
Former [1993/24]HUMANES GAMMAINTERFERON 4-134, DERIVATE, VERWENDUNGSMETHODEN UND ZUSAMMENSETZUNGEN MIT DIESEM INTERFERON
Former [1993/24]HUMAN INTERFERON-$g(g)4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS
Former [1993/24]INTERFERON-$g(g)4-134 D'ORIGINE HUMAINE, EQUIVALENTS FONCTIONNELS DE LADITE PROTEINE, PROCEDE D'UTILISATION ET COMPOSITIONS EMPLOYANT LESDITES SUBSTANCES
Entry into regional phase02.03.1993National basic fee paid 
02.03.1993Designation fee(s) paid 
02.03.1993Examination fee paid 
Examination procedure17.03.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
02.03.1993Examination requested  [1993/24]
29.09.1993Despatch of a communication from the examining division (Time limit: M04)
27.11.1993Reply to a communication from the examining division
05.01.1994Despatch of communication of intention to grant (Approval: Yes)
12.04.1994Communication of intention to grant the patent
23.06.1994Fee for grant paid
23.06.1994Fee for publishing/printing paid
Opposition(s)13.07.1995No opposition filed within time limit [1995/40]
Fees paidRenewal fee
15.07.1993Renewal fee patent year 03
12.07.1994Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.10.1994
BE12.10.1994
CH12.10.1994
DK12.10.1994
ES12.10.1994
GR12.10.1994
LI12.10.1994
NL12.10.1994
SE12.01.1995
[2002/25]
Former [2000/05]AT12.10.1994
BE12.10.1994
CH12.10.1994
DK12.10.1994
GR12.10.1994
LI12.10.1994
NL12.10.1994
SE12.01.1995
Former [1998/15]AT12.10.1994
BE12.10.1994
CH12.10.1994
DK12.10.1994
LI12.10.1994
NL12.10.1994
SE12.01.1995
Former [1995/35]AT12.10.1994
BE12.10.1994
CH12.10.1994
LI12.10.1994
NL12.10.1994
SE12.01.1995
Former [1995/30]AT12.10.1994
BE12.10.1994
CH12.10.1994
LI12.10.1994
SE12.01.1995
Former [1995/29]AT12.10.1994
CH12.10.1994
LI12.10.1994
SE12.01.1995
Former [1995/17]CH12.10.1994
LI12.10.1994
Cited inInternational search[X]EP0146354  (GENENTECH INC [US]);
 [X]EP0166993  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [Y]EP0241725  (BOEHRINGER INGELHEIM INT [DE]);
 [A]EP0256424  (HOFFMANN LA ROCHE [CH]);
 [A]EP0273373  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [A]EP0306870  (BASF AG [DE]);
 [Y]WO9002570  (SCRIPPS CLINIC RES [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.